Greg teaches the capstone course Sustainable Innovation in Healthcare: Managing Continuous Improvements in Developing Products and Services. He is also Chief Medical and Information Officer at PRA Health Sciences, a leading pharmaceutical service, healthcare data and contract research firm. Previously, he was President and Chief Medical Officer at Castle Creek Pharmaceuticals, President of Rare Disease at Moderna Therapeutics, and had leadership roles at McKinsey & Co., Quintiles, Inc., Proteostasis, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He was co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on non-profit advisory boards. Greg writes about innovation for Forbes.
Greg teaches the capstone course Sustainable Innovation in Healthcare: Managing Continuous Improvements in Developing Products and Services. He is also Chief Medical and Information Officer at PRA Health Sciences, a leading pharmaceutical service, healthcare data and contract research firm. Previously, he was President and Chief Medical Officer at Castle Creek Pharmaceuticals, President of Rare Disease at Moderna Therapeutics, and had leadership roles at McKinsey & Co., Quintiles, Inc., Proteostasis, Amicus Therapeutics, Domain Associates and Medtronic Neurological. He was co-founder of Immunome Therapeutics. Greg has degrees from Harvard Business School, Yale School of Medicine, Columbia University, and Boston College. He trained at the Brigham and Women's, Children's, and Massachusetts General Hospitals. He is on non-profit advisory boards. Greg writes about innovation for Forbes.